Acquisition (code A) of 71,250 shares at $0 per share.
Reporting Person GUDONIS PAUL R · Officer Title Chief Executive Officer · Transaction Code A
Traded Oct 13, 2026 · Disclosed Oct 15, 2026
Source: SEC Form 4 · 0001193125-26-422913 · filed 2026-10-15 · View filing →
Acquisition (code A) of 51,250 shares at $0 per share.
Reporting Person HENRY DAVID A · Officer Title Chief Financial Officer · Transaction Code A
Traded Oct 13, 2026 · Disclosed Oct 15, 2026
Source: SEC Form 4 · 0001193125-26-422923 · filed 2026-10-15 · View filing →
Acquisition (code A) of 32,500 shares at $0 per share.
Reporting Person Kovelman Harry · Officer Title Chief Medical Officer · Transaction Code A
Traded Oct 13, 2026 · Disclosed Oct 15, 2026
Source: SEC Form 4 · 0001193125-26-422937 · filed 2026-10-15 · View filing →
Sale of 15,844 shares at $1.2709 per share.
Reporting Person Kovelman Harry · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 11, 2026 · Disclosed Oct 15, 2026FILED +34 DAYS
Source: SEC Form 4 · 0001193125-26-422930 · filed 2026-10-15 · View filing →
Acquisition (code A) of 275,000 shares at $0 per share.
Reporting Person McClure Mary-Katherine Hale · Officer Title Chief Commericial Officer · Transaction Code A
Traded Oct 12, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001193125-26-419757 · filed 2026-10-13 · View filing →
Disposition (code F) of 3,133 shares at $1.37 per share.
Reporting Person HENRY DAVID A · Officer Title Chief Financial Officer · Transaction Code F
Traded Oct 12, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001193125-26-420694 · filed 2026-10-13 · View filing →
Acquisition (code A) of 8,363 shares at $0 per share.
Reporting Person GUDONIS PAUL R · Officer Title Chief Executive Officer · Transaction Code A
Traded Oct 9, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001193125-26-420689 · filed 2026-10-13 · View filing →
Acquisition (code A) of 6,272 shares at $0 per share.
Reporting Person HENRY DAVID A · Officer Title Chief Financial Officer · Transaction Code A
Traded Oct 9, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001193125-26-420694 · filed 2026-10-13 · View filing →
Sale of 15,000 shares at $1.41 per share.
Reporting Person Morris Milton Mayo · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001193125-26-383718 · filed 2026-09-04 · View filing →
Sale of 17,500 shares at $1.7331 per share.
Reporting Person Kovelman Harry · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 20, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-361870 · filed 2026-08-24 · View filing →